Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421.
Cancer treatment and research communications·2019
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
[Carotid body tumors].
Chirurgie (Heidelberg, Germany)·2026
A Systematic Three-Step Posterior Sacral Resection for High Sacrectomy (S2 and Below) in Pelvic Malignancies.
Diseases of the colon and rectum·2026
Giant low-grade endometrial stromal sarcoma with extensive sex cord-like differentiation: a case report.
International journal of surgery case reports·2026
Giant retroperitoneal leiomyosarcoma of massive proportions: a case report.
International journal of surgery case reports·2026
Atypical glomus tumors of the lower extremity: a case report of two patients.
International journal of surgery case reports·2026
Clinical and radiological features of primary breast sarcoma: a 14-year retrospective case series from a single institution.
International journal of surgery case reports·2026